FOS and breast cancer: Together with our finding that NR4A1 interacts with the DNA-binding domains of c-Fos, these results confirm the hypothesis that NR4A1 interacts with c-Fos to interfere with its genome binding, especially in the promoter region, to repress gene transcription and maintain lipid and redox homeostasis in BC cells.